With the FDA approval of Gilead's seladelpar, there have now been two in a matter of weeks. The US agency has cleared seladelpar under the Livdelzi brand name as a second-line therapy for PBC in ...

Gilead Sciences is just a few weeks away from an FDA decision on seladelpar for rare liver disease primary biliary cholangitis (PBC) and will be buoyed by new data pointing to its long-term ...

Bernstein analyst Courtney Breen maintained a Buy rating on Gilead Sciences (GILD – Research Report) yesterday and set a price target of ...

J.P. Morgan analyst Chris Schott maintained a Buy rating on Gilead Sciences (GILD – Research Report) today and set a price target of $115.00.

The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.

President Trump has appointed Chris Rocheleau as the acting FAA administrator following a tragic aircraft collision near Washington, D.C. Rocheleau, with over two decades of experience at the FAA ...

Jan. 30, 2025 — Experts from the global Earth science community have pieced together what happened during the massive Sikkim flood to try to help others prepare for ... Zika Uses Human Skin as ...

Nat Clin Pract Urol. 2009;6(2):74-75. Clinical benefit is only one facet of clinical decision making; medical risks and financial costs also need to be considered. For example, many of the ...

Food Standards Scotland (FSS) is to develop guidance for sellers of food on social media after a survey found buying products in this way was more common than predicted. Research focused on ready ...

Hepatic fibrosis is the common result of injury to the liver from a variety of damaging mechanisms, and the accurate assessment of the degree of fibrosis is clinically important. For many years ...